Malondialdehyde in exhaled breath condensate as a marker of oxidative stress in different pulmonary diseases - Wikidata - awgldk - TriplyDB

Malondialdehyde in exhaled breath condensate as a marker of oxidative stress in different pulmonary diseases

Malondialdehyde in exhaled breath condensate as a marker of oxidative stress in different pulmonary diseases

http://www.wikidata.org/entity/Q35104665

about

Oxidative stress and free radicals in COPD--implications and relevance for treatment Obesity and colorectal cancer: molecular features of adipose tissue Exhaled Breath Condensate: Technical and Diagnostic Aspects Malondialdehyde and 3-nitrotyrosine in exhaled breath condensate in retired elderly coal miners with chronic obstructive pulmonary disease Oxidative Stress in COPD: Sources, Markers, and Potential Mechanisms Predicting disease onset in clinically healthy people Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal Protective effects of Arctium lappa L. root extracts (AREs) on high fat diet induced quail atherosclerosis Neutrophilic Bronchial Inflammation Correlates with Clinical and Functional Findings in Patients with Noncystic Fibrosis Bronchiectasis Passive smoking impairs histone deacetylase-2 in children with severe asthma.Noninvasive analysis of volatile biomarkers in human emanations for health and early disease diagnosis.Exhaled breath condensate--from an analytical point of view.Malondialdehyde in exhaled breath condensate and urine as a biomarker of air pollution induced oxidative stress.The Role of Nicotinamide Adenine Dinucleotide Phosphate Oxidases in Lung Architecture Remodeling.Acute Response to Cigarette Smoking Assessed in Exhaled Breath Condensate in Patients with Chronic Obstructive Pulmonary Disease and Healthy Smokers.Biomarkers of oxidative-stress and inflammation in exhaled breath condensate from hospital cleaners.Protective effect of co-administration of rosuvastatin and probucol on atherosclerosis in rats.Exhaled breath condensate: a promising source for biomarkers of lung disease.Evaluation of oxidative stress biomarkers in idiopathic pulmonary fibrosis and therapeutic applications: a systematic review.

P2860

Q26830076-238D9A6A-3C2F-4934-9713-2EC783F4761A Q28079556-56B276B8-C78D-48ED-B48D-EF3B49419ADA Q28082250-EC832642-CAE8-45F1-8ECC-36984C49EC33 Q28393193-B003CCAE-845A-4565-B8AB-EAD4F273A663 Q29247910-2BA2A518-0DDE-4510-B7CF-8DA12ADCAE31 Q33761332-CAD2CA53-B781-4DE1-9B45-97BD1D717B57 Q33790988-B7CCF959-8510-4734-AFDA-F477D4269A36 Q35889064-72A7EB9A-F084-42C7-AD1A-C36A93EEEEA8 Q36447114-B13363E7-E442-403C-B63C-E0812E211060 Q37553296-B8F10F7A-0769-41FA-B8EB-BB9AE19039EF Q38112480-B475E533-5266-4756-9965-80775172DD3B Q38165185-02AA2FD3-BA4F-4C66-9551-6EDE8E9EBDFE Q40436064-8D3A51CA-18B3-4329-A9D2-BF2172FEF91D Q46236716-F71E8A7F-A567-454C-ABEC-DAE84A1C6396 Q51337106-20A1CD8C-4738-4F7B-B5C7-D3C795184A43 Q51566823-1994C86B-821A-46A7-A99E-6FCDB4FE2348 Q53021675-C5272980-EE18-4673-91D6-D1BB9637E728 Q55315234-22190ED4-DF5A-49DD-9177-0B51EB0262CF Q55365053-B1ED052B-A9E9-4A3E-80CF-C547100D4139

P2860

Malondialdehyde in exhaled breath condensate as a marker of oxidative stress in different pulmonary diseases

http://www.wikidata.org/entity/Q35104665

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Malondialdehyde in exhaled bre ...... n different pulmonary diseases

@ast

Malondialdehyde in exhaled bre ...... n different pulmonary diseases

@en

type

label

Malondialdehyde in exhaled bre ...... n different pulmonary diseases

@ast

Malondialdehyde in exhaled bre ...... n different pulmonary diseases

@en

prefLabel

Malondialdehyde in exhaled bre ...... n different pulmonary diseases

@ast

Malondialdehyde in exhaled bre ...... n different pulmonary diseases

@en

P1433

Q35104665-2A8E1450-09F2-4E8D-B1A7-8CECAC641188

P1476

Q35104665-B5C7B4ED-1360-4C4E-B840-AA813F3E6956

P2093

Q35104665-09DF696A-4577-411D-A636-86B35535AE34

Q35104665-109C45CD-DE80-41A8-A838-BE1C0CAFC8E1

Q35104665-49B656CC-CAE6-4008-B505-5F8B8D947113

Q35104665-4CCA1858-CDBA-4303-9C14-B58417571D6E

Q35104665-4E117F70-223E-4BDB-8959-86EBA0DE2CEF

Q35104665-6CE5FF59-2E43-4606-A541-4781B2B721F9

Q35104665-7B374923-3A52-404A-B154-B017ABCAC715

Q35104665-D01D4245-9E2F-46F6-AD2B-A12DC4801756

Q35104665-D9667CBD-2968-47DA-BBA8-C790B59517DD

Q35104665-FDF0BBAC-6EF9-402D-8710-EFD80AF0CFC1

P2860

Q35104665-1162B1C6-F0EA-4711-A9CB-0F761DA6F731

Q35104665-19F68275-E829-4709-8983-EEDC691EBD56

Q35104665-217431B2-F262-4D76-A486-FF0D5E791222

Q35104665-2CDD4B41-8B60-440E-84F4-440818A3E588

Q35104665-43CE367D-505E-439D-9B13-9C43B25DC8AE

Q35104665-4CBF4130-4210-4EC5-A94D-959F2BB5C533

Q35104665-5525905B-6023-4E76-95E5-EFDA9A532740

Q35104665-566F2D66-F2CA-4557-9C3F-BD14010C289D

Q35104665-5CEBA547-9EA1-4C22-ACF1-428C06151174

Q35104665-5DF995E3-6A59-4FFA-8F1F-7D6B6666A425

P304

Q35104665-32C39DD7-F5C4-48C7-B75E-DE23F953EB65

P31

Q35104665-2E60E6A5-E123-4474-B3FD-D98B2E726263

P356

Q35104665-ADCD3100-E6A4-48B2-B9F4-480FF177B35C

P478

Q35104665-673AFBDD-44FF-46D0-8643-A0B981B743FC

P577

Q35104665-6E0763F0-8A22-4520-95B2-035F25A3FC75

P5875

Q35104665-F72AE2CE-4B36-46E2-9049-B8EF2EDAD5A3

P698

Q35104665-C97995CF-4E91-4810-8CA1-F16D1BDA9F33

P921

Q35104665-5189D2FC-7DA5-4F1B-9B17-83DF79482767

P932

Q35104665-1618BF30-C8BD-4B72-AABF-282378FC3BFD

P356

P1433

Mediators of Inflammation

P1476

Malondialdehyde in exhaled bre ...... n different pulmonary diseases

@en

P2093

A Di Franco

http://www.w3.org/2001/XMLSchema#string

B Vagaggini

http://www.w3.org/2001/XMLSchema#string

E Bacci

http://www.w3.org/2001/XMLSchema#string

F Costa

http://www.w3.org/2001/XMLSchema#string

F L Dente

http://www.w3.org/2001/XMLSchema#string

F Novelli

http://www.w3.org/2001/XMLSchema#string

L Malagrinò

http://www.w3.org/2001/XMLSchema#string

L Melosini

http://www.w3.org/2001/XMLSchema#string

M L Bartoli

http://www.w3.org/2001/XMLSchema#string

P L Paggiaro

http://www.w3.org/2001/XMLSchema#string

P2860

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

Statistical methods for assessing agreement between two methods of clinical measurement

American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Soci

Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society

Comparison between exhaled and sputum oxidative stress biomarkers in chronic airway inflammation

Sputum induction.

Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD.

Asthma and cigarette smoking.

Airway biomarkers of the oxidant burden in asthma and chronic obstructive pulmonary disease: current and future perspectives.

Oxidants and the pathogenesis of lung diseases.

P304

891752

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2011/891752

http://www.w3.org/2001/XMLSchema#string

P478

2011

http://www.w3.org/2001/XMLSchema#string

P577

2011-06-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51505500

http://www.w3.org/2001/XMLSchema#string

P698

21772668

http://www.w3.org/2001/XMLSchema#string

P921

P932

3136125

http://www.w3.org/2001/XMLSchema#string